Navigation Links
Signalling pathways meeting targeting the HER/EGFR family: Focus on breast, lung and colorectal cancers
Date:2/25/2013

The ESMO symposium "Signalling Pathways Targeting the HER/EGFR family in breast, lung and colorectal cancers" is a unique event which will mark the start of a series of events that ESMO will specifically dedicate to issues around the widely debated topic of personalised cancer medicine.

Academic clinical researchers and industry researchers alike will be guided by an extraordinary panel of experts through the challenges and the novelties that the dissection of biomarkers are continuously bringing to the oncology field.

200 attendees are expected from throughout Europe and the rest of the world.

Highlights on:

  • Lively biomarkers: opportunities for liquid biopsy

  • Pitfalls and challenges with tumour tissue specimens

  • Tumour-host interaction: focus on immune response and microenvironment

  • EGFR/HER family targeted therapy in breast, colorectal and lung cancer

  • Adjuvant and neoadjuvant strategies in HER-2/neu breast disease

  • Predictive biomarkers of EGFR inhibition in colorectal cancer: what is there beyond KRAS?

  • Building on EGFR inhibition in lung cancer: Synthetic lethality strategies


'/>"/>

Contact: Press Office
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Page: 1

Related biology news :

1. Fragile X and Down syndromes share signalling pathway for intellectual disability
2. Thomas Jefferson University researchers discover new pathways that drive metastatic prostate cancer
3. Long-distance solute transport in trees improved by intercellular pathways in living woody tissues
4. Cleveland Clinic researchers receive $5 million grant to discover novel pathways to heart disease
5. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
6. Insects scientists and children meeting in Las Cruces, New Mexico
7. Meeting: Project aims to predict yield potential to help global food security
8. Press registration open for ASM Biodefense and Emerging Diseases Research Meeting
9. Media invited: Biophysical Society Annual Meeting
10. ACMG 2013 Clinical Genetics Meeting -- Complimentary press registration is now open
11. SSR 2013 Annual Meeting: Call for abstracts
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... YORK , May 16, 2016   EyeLock ... solutions, today announced the opening of an IoT Center ... to strengthen and expand the development of embedded iris ... an unprecedented level of convenience and security with unmatched ... authenticate one,s identity aside from DNA. EyeLock,s platform uses ...
(Date:5/9/2016)... DUBAI , UAE, May 9, 2016 ... choice when it comes to expanding freedom for high ... Even in today,s globally connected world, there ... online conferencing system could ever duplicate sealing your deal ... are obtaining second passports by taking advantage of citizenship ...
(Date:4/28/2016)... , April 28, 2016 Infosys ... (NYSE: INFY ), and Samsung SDS, a global ... that will provide end customers with a more secure, fast ...      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... but it also plays a fundamental part in enabling and ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... operations for Amgen, will join the faculty of the University of North ... adjunct professor of strategy and entrepreneurship at UNC Kenan-Flagler, with a focus on ...
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology: